|
|
 |
|
Viewing report
|
|
|
Financial Health of Biotechnology and Drugs Companies in Rest of Asia
Frost & Sullivan, Dec 2010, Pages: 38
The research services examines the financial performance of biotechnology companies across Rest of Asia across 2 broad parameters- Excellence in financial management and Excellence in risk management. The companies are analysed using over 50 financial ratios and other parameters and are grouped under these 2 categories. Each ratio has a weight assigned to obtain the final score. A weighted average score which is the sum product of the ratios and the weights thereof, was used to rank the companies in the biotechnology segment. The ratios are then grouped into financial and risk management and we gave a comprehensive ranking based on the scores under both the heads.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
